A coronavirus vaccine being developed by Novavax appears safe and elicits an immune response, according to a study published Wednesday in The New England Journal of Medicine.
Novavax coronavirus vaccine is safe, elicits immune response
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over